T1	Participants 58 92	patients with multivessel disease.
T2	Participants 327 365	patients with coronary artery disease.
T3	Participants 408 486	patients with multivessel disease suitable for treatment with either procedure
T4	Participants 590 715	Patients with multivessel disease were randomly assigned to an initial treatment strategy of CABG (n = 914) or PTCA (n = 915)
T5	Participants 1663 1763	Among diabetic patients who were being treated with insulin or oral hypoglycemic agents at base line
T6	Participants 2042 2075	patients with multivessel disease
T7	Participants 2163 2180	treated diabetics
